Point72 Asset Management L.P. 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:10 pm Sale |
2024-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Point72 Asset Management L.P. | 9,986,132 8.700% |
-5,130,364 (-33.94%) |
Filing |
| 2024-11-14 7:59 pm Purchase |
2024-09-30 | 13G | Cogent Biosciences, Inc. COGT |
Point72 Asset Management L.P. | 15,116,496 9.900% |
9,872,873 (+188.28%) |
Filing |
| 2024-02-14 4:11 pm Purchase |
2023-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Point72 Asset Management L.P. | 5,243,623 6.100% |
1,680,721 (+47.17%) |
Filing |
| 2023-06-01 5:00 pm Purchase |
2023-05-31 | 13G | Cogent Biosciences, Inc. COGT |
Point72 Asset Management L.P. | 3,562,902 5.000% |
3,562,902 (New Position) |
Filing |